Mercy BioAnalytics, Inc., a pioneer in blood-based detection of early-stage cancer, today announced data from a groundbreaking study leveraging samples from the National Lung Screening Trial (NLST).
Accord BioPharma, Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care therapies, announced today the U.S. Food and Drug ...
Men diagnosed with prostate cancer have traditionally faced two choices: do nothing and hope the tumor doesn’t grow between ...
A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.
A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.
Its rich flavor, monounsaturated fat content, and array of antioxidants make it a genuinely beneficial addition to your diet.